Search Result "steatosis hepatis"
Anabolic Androgenic Steroids Abuse and Liver Toxicity
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11 Issue: 5 Year: 2011 Page: 430-437
Author(s): M. Neri, S. Bello, A. Bonsignore, S. Cantatore, I. Riezzo, E. Turillazzi, V. Fineschi
Interrelationships between Hepatic Fat and Insulin Resistance in Non- Alcoholic Fatty Liver Disease
Journal: Current Diabetes Reviews
Volume: 6 Issue: 5 Year: 2010 Page: 341-347
Author(s): Khalida A. Lockman, Moffat J. Nyirenda
Predictors for Fibrosis Regression in Chronic HCV Patients after the Treatment with DAAS: Results of a Real-world Cohort Study
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 20 Issue: 1 Year: 2020 Page: 104-111
Author(s): Hanan Soliman,Dina Ziada,Marwa Salama,Manal Hamisa,Rehab Badawi,Nehad Hawash,Amal Selim,Sherief Abd-Elsalam
Chronic Hepatitis C, Insulin Resistance and Vascular Disease
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 3823-3829
Author(s): Andreja Trpkovic, Edith Stokic, Djordje Radak, Zoran Gluvic, Mohamed Haidara, Shaker Mousa, Dimitri P. Mikhailidis, Esma R. Isenovic
Drug-Induced Liver Injury: Mechanisms, Types and Biomarkers
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 2 Year: 2013 Page: 3011-3021
Author(s): M. Vinken, M. Maes, T. Vanhaecke, V. Rogiers
Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 2 Year: 2007 Page: 2193-2198
Author(s): Giuseppe Palasciano, Antonio Moschetta, Vincenzo O. Palmieri, Ignazio Grattagliano, Gianluca Iacobellis, Piero Portincasa
Current Treatment Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)
Journal: Current Drug Discovery Technologies
Volume: 4 Issue: 2 Year: 2007 Page: 133-140
Author(s): Poonam Mishra, Zobair M. Younossi
Non Invasive Indexes for the Assessment of Patients with Non-alcoholic Fatty Liver Disease
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 5193-5218
Author(s): Salvatore Petta, Aase Handberg, Antonio Craxi
Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 5177-5192
Author(s): Amedeo Lonardo, Silvia Sookoian, Michel Chonchol, Paola Loria, Giovanni Targher
Insulin Resistance, Non-alcoholic Fatty Liver Disease and Hepatitis C Virus Infection
Journal: Reviews on Recent Clinical Trials
Volume: 9 Issue: 3 Year: 2014 Page: 204-209
Author(s): Nicolas Goossens, Francesco Negro